A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD) - rationale and design

Christian Albus1, Manfred E Beutel, Hans-Christian Deter

  • 1Dept. of Psychosomatics and Psychotherapy, University of Cologne, Germany. christian.albus@uk-koeln.de

Insights

This study investigated a stepwise psychotherapy for coronary artery disease (CAD) patients with depression and Type D personality. The approach aims to improve depressive symptoms and quality of life in cardiac patients.

Area of Science:

  • Cardiology
  • Psychiatry
  • Psychotherapy Research

Background:

  • Depressive symptoms significantly impact quality of life, health behaviors, and prognosis in coronary artery disease (CAD) patients.
  • Previous psychotherapy trials for depressed CAD patients showed limited effects on depression and no impact on cardiac events.
  • The Type D pattern, characterized by negative affectivity and social inhibition, is common in CAD patients.

Purpose of the Study:

  • To evaluate the efficacy of a stepwise psychotherapy intervention for treating depressive symptoms and the Type D pattern in patients with CAD.
  • To assess the impact of the intervention on cardiac events, remission of depressive disorder, and health-related quality of life.

Main Methods:

  • A multicentre randomized controlled trial involving 569 CAD patients with depression (Hospital Anxiety and Depression Scale [HADS] score ≥ 8).
  • Patients were randomized (1:1) to receive either a stepwise psychotherapy intervention or a single psychosocial counseling session (control group).
  • The intervention group received initial supportive individual psychotherapy, followed by combined psychodynamic and cognitive-behavioral group therapy for persistent symptoms.

Main Results:

  • The primary efficacy variable is the change in HADS depression scores from baseline to 18 months.
  • Secondary endpoints include cardiac events, remission of depressive disorder and Type D pattern, quality of life, cardiovascular risk profile, and health care utilization up to 24 months.

Conclusions:

  • The study aims to provide evidence for an effective psychotherapy approach for comorbid depression and Type D personality in CAD patients.
  • Findings are expected to inform clinical practice and improve outcomes for this vulnerable patient population.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...